BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28666995)

  • 1. Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.
    McGrath DA; Fifield BA; Marceau AH; Tripathi S; Porter LA; Rubin SM
    EMBO J; 2017 Aug; 36(15):2251-2262. PubMed ID: 28666995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro.
    Al Sorkhy M; Fifield BA; Myers D; Porter LA
    Cell Cycle; 2016; 15(1):128-36. PubMed ID: 26771716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27.
    McAndrew CW; Gastwirt RF; Meyer AN; Porter LA; Donoghue DJ
    Cell Cycle; 2007 Aug; 6(15):1937-45. PubMed ID: 17671428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of Cdk2-Speedy/Ringo A2.
    Cheng A; Gerry S; Kaldis P; Solomon MJ
    BMC Biochem; 2005 Sep; 6():19. PubMed ID: 16191191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
    Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
    J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spy1 interacts with p27Kip1 to allow G1/S progression.
    Porter LA; Kong-Beltran M; Donoghue DJ
    Mol Biol Cell; 2003 Sep; 14(9):3664-74. PubMed ID: 12972555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RINGO/Speedy proteins, a family of non-canonical activators of CDK1 and CDK2.
    Gonzalez L; Nebreda AR
    Semin Cell Dev Biol; 2020 Nov; 107():21-27. PubMed ID: 32317145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins.
    Cheng A; Xiong W; Ferrell JE; Solomon MJ
    Cell Cycle; 2005 Jan; 4(1):155-65. PubMed ID: 15611625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spy1 expression prevents normal cellular responses to DNA damage: inhibition of apoptosis and checkpoint activation.
    Gastwirt RF; Slavin DA; McAndrew CW; Donoghue DJ
    J Biol Chem; 2006 Nov; 281(46):35425-35. PubMed ID: 16951407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.
    Porter LA; Dellinger RW; Tynan JA; Barnes EA; Kong M; Lenormand JL; Donoghue DJ
    J Cell Biol; 2002 Apr; 157(3):357-66. PubMed ID: 11980914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral nerve lesion induces an up-regulation of Spy1 in rat spinal cord.
    Huang Y; Liu Y; Chen Y; Yu X; Yang J; Lu M; Lu Q; Ke Q; Shen A; Yan M
    Cell Mol Neurobiol; 2009 May; 29(3):403-11. PubMed ID: 19082704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
    Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved Cdk inhibitors show unique structural responses to tyrosine phosphorylation.
    Swadling JB; Warnecke T; Morris KL; Barr AR
    Biophys J; 2022 Jun; 121(12):2312-2329. PubMed ID: 35614852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Spy1 protein in human non-Hodgkin's lymphomas is correlated with phosphorylation of p27 Kip1 on Thr187 and cell proliferation.
    Hang Q; Fei M; Hou S; Ni Q; Lu C; Zhang G; Gong P; Guan C; Huang X; He S
    Med Oncol; 2012 Dec; 29(5):3504-14. PubMed ID: 22492278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin E-CDK2 is a regulator of p27Kip1.
    Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
    Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells.
    Fei M; Hang Q; Hou S; Ruan C
    Int J Hematol; 2013 Oct; 98(4):446-55. PubMed ID: 24037419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.
    Ruiz EJ; Hunt T; Nebreda AR
    Mol Cell; 2008 Oct; 32(2):210-20. PubMed ID: 18951089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis.
    Fifield BA; Qemo I; Kirou E; Cardiff RD; Porter LA
    Breast Cancer Res; 2019 Dec; 21(1):140. PubMed ID: 31829284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.